TY  - BOOK
AU  - Michel,Martin C.
AU  - Wieland,Heike A.
ED  - SpringerLink (Online service)
TI  - Public-Private-Partnerships in Drug Research and Development
T2  - Handbook of Experimental Pharmacology,
SN  - 9783031758065
AV  - RM300-666 
U1  - 615 23
PY  - 2024///
CY  - Cham
PB  - Springer Nature Switzerland, Imprint: Springer
KW  - Pharmacology
KW  - Medicine
KW  - Research
KW  - Biology
KW  - Biomedical Research
N1  - Novel and proven models of Public Private and Public Private Partnerships in Healthcare An Update -- Project based Public private collaborations -- Collaborative Innovations in Childhood Cancer Therapies -- Reaching outer space and enabling the mRNA revolution a critical role of partnerships for successful drug and vaccine development -- The Alliance between the German Cancer Research Center and Bayer a retrospective of an innovative collaboration model -- Life Science Incubation at LabCentral BioLabs with Partners Extending from the US to Europe -- Innovation at the Interface between Academia and Industry The BioMed X Model -- From innovator result driven to multi actor impact oriented Public Private Partnerships Integrating the patient perspective -- The Legal Framework for PPP in Drug R&D
N2  - Collaborative approaches are becoming a key driver in drug discovery and development. They come in many types and forms ranging from project-based collaborations and strategic alliances to large international consortia. The volume discusses various types of such collaboration including the specific uses, advantages, and challenges. Based on the nature of public-private partnerships, we present views and experiences from academia, industry, and public stakeholders
UR  - http://libcon.rec.uabc.mx:2048/login?url=https://doi.org/10.1007/978-3-031-75806-5
ER  -